Assessment of Enterprise Quality and Export Performance: An Empirical Study on the Pharmaceutical Industry in IRAN
2011 (English)In: Proceedings QMOD Conference on Quality and Service Science 2011, 14th QMOD Conference 29st-31st August, 2011, San Sebastian, Spain: From LearnAbility & InnovaAbility to SustainAbility / [ed] Carmen Jaca, Ricardo Mateo and Elizabeth Viles Javier Santos, Pamplona, Spain: Servicios de Publicaciones Universidad de Navarra , 2011, 55-73 p.Conference paper (Refereed)
The main purpose of this study is to explore the relationship between export involvement and domestic market performance with focus on pharmaceutical firms. The study covers three research questions including: 1: How to assess the export involvement/performance of the Iranian pharmaceutical companies? 2: How to assess the performance of Iranian pharmaceutical companies in domestic market? 3: How to examine the relationship between export involvement/performance and domestic market performance?
An intensive literature review and integration of relevant views and models helped us to build our own framework as a conceptual and analytical model. The model consists of EXPERF model, EFQM model, Export performance evaluation, domestic performance evaluation and the relationship between domestic performance and export performance. EFQM model and respective ILL indices was used for measuring domestic performance of the organizations on nine components of leadership, policy and strategy, people, partnership and resources, processes, people results, customer results, society results and key performance results. In order to achieve true representative of Iranian pharmaceutical companies K-mean clustering algorithm has been used to cluster Iranian pharmaceutical companies. EXPERF scale was used to measure export performance of the pharmaceutical companies in Iran on three aspects of financial export performance, strategic export performance and satisfaction with the export venture. Six clusters emerged after running the clustering algorithm in MATLAB software. This software enables us to put the similar companies together. Then centroids of the clusters were chosen to verify the relationship. Then relationship between export involvement (export performance) of pharmaceutical companies and their domestic performance was determined by use of Pearson coefficient.
Pearson correlation = 0.708 and Sig= 0.026which is less than 0.0 5 then with 95% confidence we can claim that there is a significant relation between export performance of the Centroids and Domestic performance of the centroids of Iranian pharmaceutical companies and considering that the correlation
coefficient value is positive, it means better export performance will result in better domestic performance. In other words Export performance of the companies has positive direct effect on domestic performance of Iranian pharmaceutical companies. Further studies can be done on clustering of Iranian pharmaceutical companies; effects of export involvement on individual components of EFQM based performance of firms and also verification of effect of export involvement and domestic performance in other business contexts.
Place, publisher, year, edition, pages
Pamplona, Spain: Servicios de Publicaciones Universidad de Navarra , 2011. 55-73 p.
Economics and Business
IdentifiersURN: urn:nbn:se:liu:diva-74396OAI: oai:DiVA.org:liu-74396DiVA: diva2:483707
14th QMOD Conference 29st-31st August, 2011, San Sebastian, Spain: From LearnAbility & InnovaAbility to SustainAbility